Viewing Study NCT05386056

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 11:38 PM
Ignite Modification Date: 2026-04-29 @ 4:50 AM
Study NCT ID: NCT05386056
Status: UNKNOWN
Last Update Posted: 2022-11-28
First Post: 2022-05-11
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Pembrolizumab and Photodynamic Therapy in Previously Treated Metastatic Esophageal Squamous Cell Carcinoma
Sponsor: Peking University
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Esophageal Squamous Cell Carcinoma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Pembrolizumab View
None Programmed Cell Death-1 (PD1, PD-1) View
None Programmed Death-Ligand 1 (PDL1, PD-L1) View
None Photodynamic Therapy View